Abstract:There has been a recent surge of interest in the use of superparamagnetic iron oxide nanoparticles (SPIONs) as contrast agents (CAs) for magnetic resonance imaging (MRI), due to their tunable properties and their low toxicity compared with other CAs such as gadolinium. SPIONs exert a strong influence on spin-spin T₂ relaxation times by decreasing the MR signal in the regions to which they are delivered, consequently yielding darker images or negative contrast. Given the potential of these nanoparticles to enhance detection of alterations in soft tissues, we studied the MRI response of hydrophobic or hydrophilic SPIONs loaded into liposomes (magnetoliposomes) of different lipid composition obtained by sonication. These hybrid nanostructures were characterized by measuring several parameters such as size and polydispersity, and number of SPIONs encapsulated or embedded into the lipid systems. We then studied the influence of acyl chain length as well as its unsaturation, charge, and presence of cholesterol in the lipid bilayer at high field strength (7 T) to mimic the conditions used in preclinical assays. Our results showed a high variability depending on the nature of the magnetic particles. Focusing on the hydrophobic SPIONs, the cholesterol-containing samples showed a slight reduction in r₂, while unsaturation of the lipid acyl chain and inclusion of a negatively charged lipid into the bilayer appeared to yield a marked increase in negative contrast, thus rendering these magnetoliposomes suitable candidates as CAs, especially as a liver CA.

For Better or Worse, Iron Overload by Superparamagnetic Iron Oxide Nanoparticles as a MRI Contrast Agent for Chronic Liver Diseases

Biocompatible Low-Retention Superparamagnetic Iron Oxide Nanoclusters As Contrast Agents for Magnetic Resonance Imaging of Liver Tumor

Iron Overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment.

Superparamagnetic Iron Oxide Nanoparticles: Key Physicochemical Properties and Biomedical Applications

Evaluation of Non-Targeting, C- or N-pH (low) Insertion Peptide Modified Superparamagnetic Iron Oxide Nanoclusters for Selective MRI of Liver Tumors and Their Potential Toxicity in Cirrhosis

Polymer-Coated Superparamagnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Toxicity Evaluation for MRI in Mice

Superparamagnetic Iron Oxide Nanoparticles for MR Imaging and Therapy: Design Considerations and Clinical Applications.

Toxicity of Superparamagnetic Iron Oxide Nanoparticles: Research Strategies and Implications for Nanomedicine

Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging.

Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T₂ Contrast Agents for MRI

The Internalization Pathway, Metabolic Fate and Biological Effect of Superparamagnetic Iron Oxide Nanoparticles in the Macrophage-Like RAW264.7 Cell

Superparamagnetic Iron Oxide Nanoparticles: Cytotoxicity, Metabolism, and Cellular Behavior in Biomedicine Applications

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents

Radiomodulating Properties of Superparamagnetic Iron Oxide Nanoparticle (SPION) Agent Ferumoxytol on Human Monocytes: Implications for MRI-Guided Liver Radiotherapy

Enhancing organ and vascular contrast in preclinical ultra-low field MRI using superparamagnetic iron oxide nanoparticles

Superparamagnetic Iron Oxide Nanoparticles for MR Imaging of Pancreatic Cancer: Potential for Early Diagnosis Through Targeted Strategies

Transferrin-Conjugated Superparamagnetic Iron Oxide Nanoparticles As in Vivo Magnetic Resonance Imaging Contrast Agents

Study of dextran-coated superparamagnetic iron oxides nanoparticles as MRI constrast agent

Ultrasound-Triggered Bsa/Spion Hybrid Nanoclusters for Liver-Specific Magnetic Resonance Imaging

Application of superparamagnetic iron oxide nanoparticles in magnetic resonance imaging and drug delivery system

Toxicological Risk Assessments of Iron Oxide Nanocluster- and Gadolinium-Based T1MRI Contrast Agents in Renal Failure Rats